Abstract
This study described healthcare resource utilization (HRU), costs, and treatment patterns among advanced or metastatic non-small cell lung cancer (a/mNSCLC) patients with different EGFRmutation types.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have